Quantitative gas-chromatographic flame-ionization method for p-chlorophenoxyisobutyric acid in human serum and saliva.

We describe a gas-chromatographic method for p-chlorophenoxyisobutyric acid (I) the active metabolite of clofibrate. The drug and internal standards are separated from either serum or saliva by a double extraction procedure and converted to the corresponding butyl esters by reaction with iodobutane in a mixture of methanol and N,N-di-methylacetamide containing tetramethylammonium hydroxide. Within-run CV of this assay at a serum I concentration of 79.2 mg/liter was 2.3% and at a salivary I concentration of 2.5 mg/liter was 2.1%. Precision during four months of the serum and salivary assays at these concentrations was 4.1% and 6.2%, respectively. The mean serum concentration of I (12 h after dose) in patients receiving the drug at an average dose of 28.0 mg/kg per day was 109.6 mg/liter. Serum and salivary concentrations of I as determined by our procedure were used to calculate the unbound fraction of drug in human serum. Such measurements can be used to monitor therapy in patients with renal disease, where drug toxicity may arise from high concentrations of unbound I.

[1]  H. M. Solomon,et al.  Gas-chromatographic method for acetaminophen (N-acetyl-p-aminophenol) based on sequential alkylation. , 1976, Clinical chemistry.

[2]  A. Pierides,et al.  CLOFIBRATE-INDUCED MUSCLE DAMAGE IN PATIENTS WITH CHRONIC RENAL FAILURE , 1975, The Lancet.

[3]  W. Kalow,et al.  Salivary excretion of amobarbital in man , 1975, Clinical pharmacology and therapeutics.

[4]  R. Gugler,et al.  Pharmacokinetics of drugs in patients with the nephrotic syndrome. , 1975, The Journal of clinical investigation.

[5]  H. M. Solomon,et al.  A quantitative gas chromatographic determination of ethosuximide based on N-butylation. , 1975, Clinica chimica acta; international journal of clinical chemistry.

[6]  A. Tuong,et al.  Quantitative determination of p-chlorophenoxyisobutyric acid in blood plasma by gas-liquid chromatography. , 1975, Journal of chromatography.

[7]  A. Karmen,et al.  Assay of clofibrate in human serum by gas chromatography. , 1975, Biochemical medicine.

[8]  A. Berlin Quantitative gas chromatographic determination of clofibrinic acid in plasma , 1975, The Journal of pharmacy and pharmacology.

[9]  D. Dvornik,et al.  A gas-liquid chromatographic determination of p-chlorophenoxyisobutyric acid and its comparison to an ultra violet method. , 1975, Clinical biochemistry.

[10]  H. M. Solomon,et al.  Gas-chromatographic determination of theophylline in human serum and saliva. , 1975, Clinical Chemistry.

[11]  J. Karam,et al.  Pharmacokinetics of tolbutamide: Prediction by concentration in saliva , 1974, Clinical pharmacology and therapeutics.

[12]  R. H. Greeley Rapid esterification for gas chromatography. , 1974, Journal of chromatography.

[13]  H. Nakamura,et al.  Determination of clofibrate in biological fluids by thin-layer and gas-liquid chromatography. , 1974, Journal of lipid research.

[14]  W Bastain,et al.  Salivary excretion of paracetamol in man , 1973, The Journal of pharmacy and pharmacology.

[15]  J. Thorp,et al.  Complications during clofibrate treatment of nephrotic-syndrome hyperlipoproteinaemia. , 1972, Lancet.

[16]  M. Rowland,et al.  Application of salivary salicylate data to biopharmaceutical studies of salicylates. , 1972, Journal of pharmaceutical sciences.

[17]  K. Dawson,et al.  Value of blood phenytoin estimation in management of childhood epilepsy. , 1971, Archives of disease in childhood.

[18]  J. Thorp EXPERIMENTAL EVALUATION OF AN ORALLY ACTIVE COMBINATION OF ANDROSTERONE WITH ETHYL CHLOROPHENOXYISOBUTYRATE , 1962 .